Q32 Bio Inc. (QTTB) › Operating IncomeQ32 Bio Inc. (QTTB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$29.66M2018: -$59.93M2019: -$109.94M2020: -$130.26M2021: -$95.95M2022: -$133.28M2023: -$48.26M2024: -$66.10M2025: $16.90M$16.90M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$16.90M+125.6%2024-$66.10M-37.0%2023-$48.26M+63.8%2022-$133.28M-38.9%2021-$95.95M+26.3%2020-$130.26M-18.5%2019-$109.94M-83.5%2018-$59.93M-102.1%2017-$29.66M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share